Khan, Reas S <br/><br/>
Effects of Varying Intranasal Treatment Regimens in ST266-Mediated Retinal Ganglion Cell Neuroprotection.  [electronic resource] 

 -  Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society  06 2019 
 - 191-199 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1536-5166 
<br/><br/><label>Standard No.: </label>10.1097/WNO.0000000000000760  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Intranasal<br/>Amnion<br/>Animals<br/>Cell Survival--physiology<br/>Disease Models, Animal<br/>Encephalomyelitis, Autoimmune, Experimental--physiopathology<br/>Female<br/>Intercellular Signaling Peptides and Proteins--metabolism<br/>Mice<br/>Mice, Inbred C57BL<br/>Multipotent Stem Cells--metabolism<br/>Neuroprotection--drug effects<br/>Neuroprotective Agents--metabolism<br/>Nystagmus, Optokinetic--physiology<br/>Optic Neuritis--physiopathology<br/>Retinal Diseases--physiopathology<br/>Retinal Ganglion Cells--drug effects<br/>Visual Acuity--physiology